On Nov 13, 2023, GeoInvesting’s Maj Soueidan and MSMicrocap’s Jan Svenda engaged in a Skull Session Fireside Chat with Cipher Pharmaceuticals, Inc. (OTC:CPHRF) (CPH.TO) CEO Craig Mull and CFO Bryan Jacobs. They discussed the company’s recent quarter results, its future plans, and its significant growth in licensing revenue, attributing the success to strategic sales tactics and increased market share against generic competitors.
The conversation also touched on the MLB 15 product, with Mull emphasizing the European approval as a major milestone. He outlined plans for the product's initial launch in Scandinavian countries and expresses confidence in its success, especially with the completion of the US study ahead of schedule.
The interview also focused on potential acquisitions, with Mull noting the competitive environment and the company's focus on mature products in the dermatology category. The CFO, Jacobs, shed some light on the official launch of the Purist brand in Mexico, detailing the arrangement with the manufacturer and distributor. Throughout the interview, the executives emphasize the company's cautious and strategic approach to growth and acquisitions.
